A comprehensive mathematical model of drug release kinetics from nano-liposomes, derived from optimization studies of cationic PEGylated liposomal doxorubicin formulations for drug-gene delivery

scientific article published on 4 April 2017

A comprehensive mathematical model of drug release kinetics from nano-liposomes, derived from optimization studies of cationic PEGylated liposomal doxorubicin formulations for drug-gene delivery is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1080/21691401.2017.1304403
P698PubMed publication ID28376641

P50authorBehrouz Zandieh-DoulabiQ87863228
Ghassem AmoabedinyQ91934150
P2093author name stringMarco N Helder
Tymour Forouzanfar
Mohammad Hasan Sheikhha
Fateme Haghiralsadat
Samira Naderinezhad
P2860cites workEfficient delivery of plasmid DNA using cholesterol-based cationic lipids containing polyamines and ether linkagesQ33755551
Multifunctional nanoparticles delivering small interfering RNA and doxorubicin overcome drug resistance in cancer.Q33991008
Cholesterol derivatives based charged liposomes for doxorubicin delivery: preparation, in vitro and in vivo characterizationQ34506844
Targeting JNK-interacting-protein-1 (JIP1) sensitises osteosarcoma to doxorubicinQ37031277
Surface proteomic analysis of osteosarcoma identifies EPHA2 as receptor for targeted drug deliveryQ37235596
Recent advancements in the cardiovascular drug carriersQ38232209
Modulation of induced cytotoxicity of doxorubicin by using apoferritin and liposomal cagesQ38928086
Co-delivery of doxorubicin and plasmid by a novel FGFR-mediated cationic liposomeQ39711348
The use of PEGylated liposomes to prolong circulation lifetimes of tissue plasminogen activator.Q43298207
A simple method to achieve high doxorubicin loading in biodegradable polymersomesQ43528881
PEGylated PLGA nanoparticles as protein carriers: synthesis, preparation and biodistribution in ratsQ43557085
Release kinetics of hydrophobic and hydrophilic model drugs from pluronic F127/poly(lactic acid) nanoparticles.Q45264747
New liposomal doxorubicin nanoformulation for osteosarcoma: Drug release kinetic study based on thermo and pH sensitivityQ48314799
The accumulation of drugs within large unilamellar vesicles exhibiting a proton gradient: a survey.Q51739405
P433issue1
P921main subjectdoxorubicinQ18936
mathematical modelQ486902
P304page(s)169-177
P577publication date2017-04-04
P1433published inArtificial cells, nanomedicine, and biotechnologyQ27724536
P1476titleA comprehensive mathematical model of drug release kinetics from nano-liposomes, derived from optimization studies of cationic PEGylated liposomal doxorubicin formulations for drug-gene delivery
P478volume46

Reverse relations

cites work (P2860)
Q55710454Codelivery of doxorubicin and JIP1 siRNA with novel EphA2-targeted PEGylated cationic nanoliposomes to overcome osteosarcoma multidrug resistance.
Q47375034EphA2 Targeted Doxorubicin-Nanoliposomes for Osteosarcoma Treatment
Q57022278Liposomal formulations of carboplatin injected by convection-enhanced delivery increases the median survival time of F98 glioma bearing rats
Q90219127Nanostructured lipid carriers for MicroRNA delivery in tumor gene therapy
Q92066362Preparation and Evaluation of A Novel Liposomal Nano-Formulation in Metastatic Cancer Treatment Studies
Q90257419Preparation of ginsenoside compound-K mixed micelles with improved retention and antitumor efficacy

Search more.